Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials
From MaRDI portal
Publication:118080
DOI10.2307/2531910zbMath0707.62262WikidataQ52570205 ScholiaQ52570205MaRDI QIDQ118080
Edward Lakatos, Edward Lakatos
Publication date: March 1988
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2531910
noncompliance; sample size; Markov process; nonproportional hazards; log-rank statistic; staggered entry; Tarone-Ware class; complex clinical trials
62P10: Applications of statistics to biology and medical sciences; meta analysis
Related Items
A note on variance estimation in the Cox proportional hazards model, The Influence of Biostatistics at the National Heart, Lung, and Blood Institute, Sample size calculation for two‐arm trials with time‐to‐event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions, Sample size calculation for the combination test under nonproportional hazards, nphPower, The effect of grouping on the power of the Mantel-Haenszel test for the comparison of survival rates, Data monitoring in complex clinical trials: Which treatment is better?, Sample size calculation for the proportional hazards model with a time-dependent covariate, A comparison of the constant piecewise weighted logrank and Fleming-Harrington tests, Sample size calculation for clustered survival data under subunit randomization, Calculation of Sample Size in Survival Trials: The Impact of Informative Noncompliance
